← Leaderboards
Dan E Berkowitz
Johns Hopkins University
$6,149,594
Attributed
$6,955,654
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $804.1K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,955,654 · 4
By mechanism
R01$6,955,654 · 4
Top collaborators
- Lewis H Romer4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Lewis H Romer$4,668,241
- King-Wai Yau$28,664,002
- Peter R Rapp$7,647,958
- Nicholas A Flavahan$8,622,693
- David Alan Kass$45,555,857
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsMediatingInhibitor/AntagonistProteinsSignal TransductionIn VivoEndotheliumTissuesEnzymesFunctional DisorderRattusReactive Oxygen SpeciesEndothelial CellsRegulationVasodilationResearch StudyCardiovascular SystemNitric Oxide SynthaseArginineArginaseAgingLeadPathway InteractionsHypertension
Grant awards (18)
Non-Visual Opsins & Vasoregulation: Implications for Vascular Therapy$402,881
R01 · FY2018 · HL · contact PI
Non-Visual Opsins & Vasoregulation: Implications for Vascular Therapy$402,880
R01 · FY2017 · HL · contact PI
Non-Visual Opsins & Vasoregulation: Implications for Vascular Therapy$400,401
R01 · FY2016 · HL · contact PI
Non-Visual Opsins & Vasoregulation: Implications for Vascular Therapy$409,701
R01 · FY2015 · HL · contact PI
Arginase II, A Novel Target in Atherosclerosis$401,800
R01 · FY2014 · HL · contact PI
Arginase II, A Novel Target in Atherosclerosis$390,320
R01 · FY2013 · HL · contact PI
Transglutaminase 2 S-Nitrosylation: Role in Age-Related Vascular Stiffness$375,170
R01 · FY2013 · HL · contact PI
Arginase II, A Novel Target in Atherosclerosis$410,000
R01 · FY2012 · HL · contact PI
Transglutaminase 2 S-Nitrosylation: Role in Age-Related Vascular Stiffness$394,086
R01 · FY2012 · HL · contact PI
Arginase II, A Novel Target in Atherosclerosis$410,000
R01 · FY2011 · HL · contact PI
Transglutaminase 2 S-Nitrosylation: Role in Age-Related Vascular Stiffness$388,466
R01 · FY2011 · HL · contact PI
Transglutaminase 2 S-Nitrosylation: Role in Age-Related Vascular Stiffness$404,466
R01 · FY2010 · HL · contact PI
Arginase and the Aging Cardiovascular System$152,520
R01 · FY2008 · AG · contact PI
Arginase and the Aging Cardiovascular System$387,569
R01 · FY2007 · AG · contact PI
Arginase and the Aging Cardiovascular System$399,144
R01 · FY2006 · AG · contact PI
Arginase and the Aging Cardiovascular System$408,750
R01 · FY2005 · AG
Arginase and the Aging Cardiovascular System$408,750
R01 · FY2004 · AG
Arginase and the Aging Cardiovascular System$408,750
R01 · FY2003 · AG